
Net Profit Surges 23% in Q4, Reaches Rs 1,392.3 Crore
LTM Posts 23.37% Rise in Consolidated Net Profit for Q4 FY26
IT major LTM (formerly LTIMindtree) has reported a significant increase in its consolidated net profit for the January-March quarter of FY26. The company's net profit rose by 23.37 per cent to Rs 1,392.3 crore in Q4 FY26, up from Rs 1,128.5 crore in the same period of the preceding fiscal.
LTM's revenue from operations also saw a notable increase, rising by 15.55 per cent to Rs 11,291.7 crore in Q4 FY26, compared to Rs 9,771.7 crore in Q4 FY25. On a quarter-on-quarter basis, the company's profit and revenue climbed 43.44 per cent and 4.73 per cent, respectively.
For the full fiscal year of 2025-26, LTM's profit was 9.12 per cent higher at Rs 5,018.1 crore, while revenue from operations was up 11.31 per cent at Rs 42,307.6 crore. The company's strategic shift to an AI-centric organisation, led by the BlueVerse platform and talent transformation, has unlocked new levels of efficiencies through its Fit4Future programme.
Read also: IKS Health Acquires TruBridge for $565 Million to Expand US Healthcare Presence
LTM has also announced the appointment of Vipul Chandra as Additional Director designated as Whole-time Director & Chief Financial Officer for a period of 4 years, effective from April 23, 2026. The company's total employee count at the end of FY26 stood at 87,950, up from 84,307 in Q4 FY25.
| Metric | Q4 FY25 | Q4 FY26 | % Change |
|---|---|---|---|
| Revenue from Operations (Rs crore) | 9,771.7 | 11,291.7 | 15.55% |
| Consolidated Net Profit (Rs crore) | 1,128.5 | 1,392.3 | 23.37% |
LTM's board has recommended a final dividend of Rs 53 per equity share of Re 1 each. Shares of LTM settled 1.83 per cent lower at Rs 4,520.25 apiece on the BSE on Thursday. The financial numbers were announced post-market hours.
Investor Takeaway
Investors should take note of the company's strategic shift to an AI-centric organisation and its positive impact on profits.
More in Market

IKS Health Acquires TruBridge for $565 Million to Expand US Healthcare Presence

Balrampur Chini to Raise Rs 450 Crore Equity Fund for Lactose Derivatives Plant Expansion

Tata Capital's Motor Finance Business Records Profitability in Q4, Posts 51% PAT Growth
